Efficacy of Autologous Fibroblasts on Facial Rejuvenation: A Pilot Study

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand0 个研究点目标入组 30 人开始时间: 2022年7月31日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Aged 18 older
•2. Patient with wrinkle at cheek and periorbital with score of -2 to -1 by wrinkle patient assessment score which have 5 score : Very satisfied(+2), Satisfied(+1), Mild satisfied(0), not satisfied(-1), very not satified(-2)

•1. Patients who are pregnant, lactating, and postpartum.
•2.Patient with autoimmune disease, transplantation, cancer, fibroblast or collagen genetic disorder for example Epidermolysis bullosa, Ataxia telangiectasis, skin cancer or others disease that affect the research.
•3.Patient with history of treatment by autologous fibroblast .
•4.Patient with history of treatment by inject any substances at cheek or lower face in 12 months before the research.
•5.Patient with history of treatment by focus ultrasound or ablative laser or others that affect the cheek or lower face in 12 months before the research.
•6.Patient with history of treatment by ultra phono, chemical peeling and cream or drug for treat wrinkle like tretinoin at cheek or lower face within 1 month.
•7.Allergy to collagen , diary products, Gentamicin A, Amphotericin B and local anesthesia.
•8.Patient with bleeding precaution, thrombocytopenia, take an anti-platelet drug that cannot stop and taking steroid drug or immunosuppressive drug.
•9.Patient with history of hypertrophic scar or Keloid .

发起方

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand